The Effective Statistician - in association with PSI
The Effective Statistician - in association with PSI
Episode Archive
-
Why to present better and how as a statistician
In this episode, I talk with my long-time friend and frequent guest, Kaspar Rufibach, about a skill that quietly determines how much impact we really have: presenting and communicating our work....
-
External control arms - how to get to a good one
In this episode, I’m joined by Deepa Jahagirdar, Associate Research Principal at Cytel, to explore what it really takes to build a good external control arm (ECA). Deepa brings a fascinating bac...
-
Top 9: Non-parametric analyses - much more than just the Wilcoxon test!
Why this episode made our all-time Top 9: If you’ve ever thought “non-parametric = Wilcoxon/Mann-Whitney and that’s it,” this conversation will happily destroy that myth. Frank shows how rank-ba...
-
How to communicate results from adaptive studies simple, but still correct
Adaptive designs let us learn earlier, stop smarter, and protect patients—but they also make communication tricky. In this episode, Kaspar Rufibach and I dig into what “still correct” looks like...
-
Introduction to adaptive designs and ICH E20
In this episode, I’m joined once again by my friend and frequent guest, Kaspar Rufibach, to talk about a topic that’s been around for decades but is gaining fresh attention thanks to the new ICH...
-
Leadership, Influence & Presenting: Human Skills That Make Statisticians Effective
This episode is a little different because Alun turns the microphone toward me. After 456 episodes, it feels both strange and exciting to be the “guest” on my own show. Together, we reflect on t...
-
Top 8: The Single Arm Studies and What are the Alternatives?
I’m excited to reshare one of our most-played conversations—the one where Norwegian regulator/HTA leader Anja Schiel and I get very practical about when single-arm trials fail decision-makers an...
-
Top 7: How to work with a physician within Pharma to become a valuable partner
As statisticians in pharma, one of the most important professional relationships we can build is with our physician colleagues. When this partnership works well, studies run smoother, decisions ...
-
Top 6: What is EU HTA and why should statisticians care?
This is one of our most downloaded episodes ever, and I’m excited to bring it back in this replay. In this conversation, I spoke with Lara Wolfson (MSD) and Anders Gorst-Rasmussen (Novo Nordisk)...
-
Top 5: The analysis of adverse events done right
We’re bringing back one of our most downloaded episodes ever – a deep dive into how adverse events should be analyzed properly. This conversation with Jan Beyersmann and Kaspar Rufibach is packe...